Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Chatellier

Showing results (1-10 of 273) with videos related to

Pageof 28
Sort By:
La Revue Du Praticien|November 1, 1990
[Treatment-resistant arterial hypertension]G Chatellier
La Revue Du Praticien|March 15, 1993
[Tetrahydroaminoacridine or THA. Disputed value in Alzheimer's type dementia]G Chatellier
Journal of Human Hypertension|August 1, 1995
[How to evaluate the contribution of fixed dose combinations: the standpoint of the methodologist]G Chatellier
Revue D'Epidemiologie Et De Sante Publique|August 1, 1996
[Randomized study of n-of-1 trials versus standard practice]G Chatellier
La Revue Du Praticien|December 8, 1988
[Risks in lowering blood pressure]G Chatellier
BMJ (Clinical Research Ed.)|February 24, 1990
Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la TetrahydroaminoacridineG Chatellier, L Lacomblez
Journal of Hypertension|October 1, 1995
Mild hypertension: the mysterious viability of a faulty conceptJ Ménard, G Chatellier
Diabetologia|December 1, 1996
The DIAB-HYCAR StudyP Passa, G Chatellier
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 1, 1996
Integration of trial, meta-analysis and cohort results with treatment guidelinesJ Ménard, G Chatellier
Journal of Hypertension|March 1, 1997
The absolute risk as a guide to influence the treatment decision-making process in mild hypertensionG Chatellier, J Ménard
Pageof 28

Showing results (1-10 of 273) with videos related to

Sort By:
Pageof 28
La Revue Du Praticien|November 1, 1990
[Treatment-resistant arterial hypertension]G Chatellier
La Revue Du Praticien|March 15, 1993
[Tetrahydroaminoacridine or THA. Disputed value in Alzheimer's type dementia]G Chatellier
Journal of Human Hypertension|August 1, 1995
[How to evaluate the contribution of fixed dose combinations: the standpoint of the methodologist]G Chatellier
Revue D'Epidemiologie Et De Sante Publique|August 1, 1996
[Randomized study of n-of-1 trials versus standard practice]G Chatellier
La Revue Du Praticien|December 8, 1988
[Risks in lowering blood pressure]G Chatellier
BMJ (Clinical Research Ed.)|February 24, 1990
Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la TetrahydroaminoacridineG Chatellier, L Lacomblez
Journal of Hypertension|October 1, 1995
Mild hypertension: the mysterious viability of a faulty conceptJ Ménard, G Chatellier
Diabetologia|December 1, 1996
The DIAB-HYCAR StudyP Passa, G Chatellier
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 1, 1996
Integration of trial, meta-analysis and cohort results with treatment guidelinesJ Ménard, G Chatellier
Journal of Hypertension|March 1, 1997
The absolute risk as a guide to influence the treatment decision-making process in mild hypertensionG Chatellier, J Ménard
Pageof 28